News

The Pharma Letter4h
AstraZeneca at plenary again with pivotal ASCO data
UK pharma major AstraZeneca (LSE: AZN) is set to present data from more than 80 studies at the 2025 American Society of ...
Immunotherapy Drugs (Monoclonal Antibodies, Immunomodulators, Vaccine) Market Size, Share & Trends Analysis and Growth Forecasts, 2025-2030
The Immunotherapy Drugs Market is set to grow from USD 257.60 billion in 2024 to USD 486.36 billion by 2030, with a CAGR of ...
Pharmabiz10h
AstraZeneca’s record seventh year of plenary data at ASCO furthers ambition to redefine breast cancer care and transform outcomes in gastric cancer
AstraZeneca’s record seventh year of plenary data at ASCO furthers ambition to redefine breast cancer care and transform outcomes in gastric cancer: Cambridge, UK Thursday, May ...
The Pharma Letter22h
Big build-up for AstraZeneca’s ASCO offering
Anglo-Swedish pharma major AstraZeneca reports that it will have a historic presence at this year’s American Society of ...
AstraZeneca Stock Declines 6% in 3 Months: Time to Buy the Dip?
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.